Nelumbo Investments Limited - Net Worth and Insider Trading
Nelumbo Investments Limited Net Worth
The estimated net worth of Nelumbo Investments Limited is at least $3.6 Billion dollars as of 2024-06-21. Nelumbo Investments Limited is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd and owns about 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) stock worth over $3.6 Billion. Details can be seen in Nelumbo Investments Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nelumbo Investments Limited has not made any transactions after 2024-04-10 and currently still holds the listed stock(s).
Transaction Summary of Nelumbo Investments Limited
Nelumbo Investments Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nelumbo Investments Limited owns 1 companies in total, including Luye Pharma Group Ltd (HKSE:02186) .
Click here to see the complete history of Nelumbo Investments Limited’s form 4 insider trades.
Insider Ownership Summary of Nelumbo Investments Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02186 | Luye Pharma Group Ltd | 2024-04-10 | 2201 Interest of corporation controlled by you |
Nelumbo Investments Limited Latest Holdings Summary
Nelumbo Investments Limited currently owns a total of 1 stock. Nelumbo Investments Limited owns 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) as of April 10, 2024, with a value of $3.6 Billion.
Latest Holdings of Nelumbo Investments Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02186 | Luye Pharma Group Ltd | 2024-04-10 | 1,259,196,703 | 2.84 | 3,576,118,637 |
Holding Weightings of Nelumbo Investments Limited
Nelumbo Investments Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Nelumbo Investments Limited has made a total of 12 transactions in Luye Pharma Group Ltd (HKSE:02186) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Luye Pharma Group Ltd is the sale of 0 shares on April 10, 2024, which brought Nelumbo Investments Limited around $0.
Insider Trading History of Nelumbo Investments Limited
- 1
Nelumbo Investments Limited Trading Performance
GuruFocus tracks the stock performance after each of Nelumbo Investments Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nelumbo Investments Limited is -16.72%. GuruFocus also compares Nelumbo Investments Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nelumbo Investments Limited within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nelumbo Investments Limited's insider trading performs compared to the benchmark.
Performance of Nelumbo Investments Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.49 |  | | | | |
| Relative Return to S&P 500(%) | -27.47 | | | | | |
Nelumbo Investments Limited Ownership Network
Nelumbo Investments Limited Owned Company Details
What does Luye Pharma Group Ltd do?
Who are the key executives at Luye Pharma Group Ltd?
Nelumbo Investments Limited is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd. Other key executives at Luye Pharma Group Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2301 Trustee Liu Dianbo , and 2101 Beneficial owner LuYe Pharmaceutical Investment Co., Ltd. .
Luye Pharma Group Ltd (HKSE:02186) Insider Trades Summary
Over the past 18 months, Nelumbo Investments Limited made 10 insider transaction in Luye Pharma Group Ltd (HKSE:02186) with a net purchase of 2,000,000. Other recent insider transactions involving Luye Pharma Group Ltd (HKSE:02186) include a net sale of 73,433,500 shares made by UBS Group AG , a net purchase of 2,000,000 shares made by Liu Dianbo , and a net purchase of 2,000,000 shares made by Luye Pharma Holdings Ltd. .
In summary, during the past 3 months, insiders sold 0 shares of Luye Pharma Group Ltd (HKSE:02186) in total and bought 3,569,500 shares, with a net purchase of 3,569,500 shares. During the past 18 months, 77,003,000 shares of Luye Pharma Group Ltd (HKSE:02186) were sold and 26,200,500 shares were bought by its insiders, resulting in a net sale of 50,802,500 shares.
Luye Pharma Group Ltd (HKSE:02186)'s detailed insider trading history can be found in Insider Trading Tracker table.
Luye Pharma Group Ltd Insider Transactions
Nelumbo Investments Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Nelumbo Investments Limited. Currently GuruFocus does not have mailing address information for Nelumbo Investments Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
